Thornburg Investment Management Inc Biomarin Pharmaceutical Inc Transaction History
Thornburg Investment Management Inc
- $6.65 Billion
- Q1 2025
A detailed history of Thornburg Investment Management Inc transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Thornburg Investment Management Inc holds 85,427 shares of BMRN stock, worth $5.04 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
85,427
Previous 96,881
11.82%
Holding current value
$5.04 Million
Previous $6.37 Million
5.17%
% of portfolio
0.09%
Previous 0.09%
Shares
9 transactions
Others Institutions Holding BMRN
# of Institutions
666Shares Held
185MCall Options Held
1.24MPut Options Held
957K-
Black Rock Inc. New York, NY22.7MShares$1.34 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.12 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA17.8MShares$1.05 Billion1.06% of portfolio
-
Dodge & Cox San Francisco, CA15MShares$883 Million0.65% of portfolio
-
Viking Global Investors LP10.8MShares$637 Million2.55% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $11B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...